Bristol-Myers Squibb Company
BMYFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
48,300
Cost of Revenue
20,868
Gross Profit
27,432
Gross Margin
56.8%
Operating Income
9,658
Operating Margin
20.0%
Net Income
-8,948
Net Margin
-18.5%
EPS (Basic)
$-4.41
EPS (Diluted)
$-4.41
EBITDA
3,168
EBITDA Margin
6.6%
2023
12/31/2023
Revenue
45,006
Cost of Revenue
19,649
Gross Profit
25,357
Gross Margin
56.3%
Operating Income
8,472
Operating Margin
18.8%
Net Income
8,025
Net Margin
17.8%
EPS (Basic)
$3.88
EPS (Diluted)
$3.86
EBITDA
19,366
EBITDA Margin
43.0%
2022
12/31/2022
Revenue
46,159
Cost of Revenue
19,669
Gross Profit
26,490
Gross Margin
57.4%
Operating Income
9,271
Operating Margin
20.1%
Net Income
6,327
Net Margin
13.7%
EPS (Basic)
$2.97
EPS (Diluted)
$2.95
EBITDA
19,221
EBITDA Margin
41.6%
2021
12/31/2021
Revenue
46,385
Cost of Revenue
19,624
Gross Profit
26,761
Gross Margin
57.7%
Operating Income
9,540
Operating Margin
20.6%
Net Income
6,994
Net Margin
15.1%
EPS (Basic)
$3.15
EPS (Diluted)
$3.12
EBITDA
20,118
EBITDA Margin
43.4%
2020
12/31/2020
Revenue
42,518
Cost of Revenue
20,818
Gross Profit
21,700
Gross Margin
51.0%
Operating Income
4,492
Operating Margin
10.6%
Net Income
-8,995
Net Margin
-21.2%
EPS (Basic)
$-3.98
EPS (Diluted)
$-3.98
EBITDA
4,929
EBITDA Margin
11.6%